NCM Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
NCM Capital Management's BMY Position: Q3 2026 in Review
NCM Capital Management increased its Bristol-Myers Squibb (BMY) stake by 0.03% in Q3 2026, buying an estimated $379 and bringing the position to 18,728 shares worth $1.17M. The position accounts for 0.36% of the portfolio, ranked #69.
NCM Capital Management first reported a position in BMY in Q4 2021 and has held it in 20 quarters since. The position peaked at $1.3M in Q1 2025. 2,567 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- NCM Capital Management held 18,728 shares of Bristol-Myers Squibb worth $1.17M as of Q3 2026.
- NCM Capital Management bought 6 Bristol-Myers Squibb shares in Q3 2026, an estimated $379.
- Bristol-Myers Squibb made up 0.36% of NCM Capital Management's portfolio in Q3 2026, its #69 holding.
- NCM Capital Management first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 20 quarters since.
- NCM Capital Management's Bristol-Myers Squibb position peaked at $1.3M in Q1 2025.
- 2,567 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on NCM Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.